Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | BLISSGVS Bliss GVS Pharma Limited Pharma · Small | FDC FDC Limited Pharma · Small | NOVARTIND Novartis India Limited Pharma · Small | ZOTA Zota Health Care LImited Pharma · Small |
|---|---|---|---|---|
| Final Score | 44 | 39 | 45 | 28 |
| Verdict | WATCHLIST | WATCHLIST | WATCHLIST | OVERVALUED |
| Style | WATCHLIST | WATCHLIST | Financial Turnaround | OVERVALUED |
| Piotroski | 8/9 | 8/9 | 7/9 | 5/9 |
| Valuation | 5/30 | 5/30 | 5/30 | 1/30 |
| Growth | 13/25 | 8/25 | 15/25 | 14/25 |
| Quality | 4/20 | 2/20 | 2/20 | 0/20 |
| Balance Sheet | 10/15 | 14/15 | 13/15 | 7/15 |
| Cash Flow | 8/10 | 5/10 | 5/10 | 3/10 |
| Price | ₹421.6 | ₹394 | ₹1,331.4 | ₹1,211.2 |
| P/E | 34.20 | 21.60 | 36.90 | 147.00 |
| P/B | 3.73 | 2.58 | 4.20 | 4.73 |
| ROE | 11.60% | 12.50% | 11.60% | 4.74% |
| ROCE | 16.80% | 16.70% | 16.20% | 6.68% |
| Debt / Equity | 0.02 | 0.01 | 0.00 | 0.02 |
| FCF Yield | 2.26% | 1.40% | 1.89% | — |
| Dividend Y | 0.12% | 1.27% | 1.80% | 0.08% |
| Altman Z | 8.38 | 8.63 | 8.13 | 8.00 |
| Promoter % | 35.36% | 69.65% | 70.68% | 49.38% |
| Mkt Cap (₹Cr) | 4465.00 | 6410.00 | 3435.00 | 4195.00 |
| Graham # | ₹176.19 | ₹243.97 | ₹530.16 | ₹215.47 |
| Fair PE | 42.0 | 8.7 | 42.0 | 42.0 |
| MoS % | +17.8% | -161.7% | +16.0% | -257.8% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startBLISSGVS339
FDC76
NOVARTIND138
ZOTA205